Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of...
Verve Therapeutics’ $306 Million IPO
FARO Technologies’ $34 Million Acquisition of HoloBuilder
Wilmer Cutler Pickering Hale and Dorr LLP advised HoloBuilder, Inc. on the deal. HoloBuilder, Inc., a German-American construction technology-startup, announced its acquisition by FARO Technologies, Inc.,...
Amplitude Healthcare’s Business Combination with Jasper Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics. Amplitude Healthcare Corporation (Nasdaq: AMHC), a special...
WEX’s Acquisition of benefitexpress
Wilmer Cutler Pickering Hale and Dorr LLP advised WEX, Inc. on the deal. WEX, Inc., a leading financial technology service provider, announced the signing of an...